Ganta, Roman R.
- University of Missouri-Columbia (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #4,253
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
NIH Funding · FY2023
Linked Award Amount
$1.9M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#4,253
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Ganta, Roman R. as a PI. Multi-PI records show the full award amount for context.
- 5R01AI152417-04R01Contact PIRocky Mountain Spotted Fever Vaccine Development$719Kaward amount
- 7R01AI152418-04R01Contact PIVaccines Against Ehrlichia and Anaplasma Species Infections$598.8Kaward amount
- 7R01AI070908-14R01Contact PIVector and Host Contributions to the Regulation of E. chaffeensis Gene$545.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Ganta, Roman R. as a PI.
FY2023 award administered by University of Missouri-Columbia (MO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardUniversity of Missouri-Columbia
- 2007$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2011$2M Cumulative Funding
- 2011R01 Grant Holder
- 2019$5M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #3690
- 2021Entered Top 25% NationallyRanked #3690
- 2023$10M Cumulative Funding